Reaktionsgleichung
Br[CH2:2][CH2:3][CH2:4][CH2:5][C:6]([O:8][CH2:9][CH3:10])=[O:7].[Cl:11][C:12]1[CH:13]=[N:14][CH:15]=[C:16]([Cl:33])[C:17]=1[NH:18][C:19]1[C:28]2[C:23](=[C:24]([OH:31])[C:25]([O:29][CH3:30])=[CH:26][CH:27]=2)[O:22][C:21](=[O:32])[CH:20]=1>>[Cl:11][C:12]1[CH:13]=[N:14][CH:15]=[C:16]([Cl:33])[C:17]=1[NH:18][C:19]1[C:28]2[C:23](=[C:24]([O:31][CH2:2][CH2:3][CH2:4][CH2:5][C:6]([O:8][CH2:9][CH3:10])=[O:7])[C:25]([O:29][CH3:30])=[CH:26][CH:27]=2)[O:22][C:21](=[O:32])[CH:20]=1Komponenten
3
Versuchsvorschrift
The title compound was prepared from ethyl 5-bromopentanoate and 4-(3,5-dichloropyridin-4-ylamino)-8-hydroxy-7-methoxy-2H-chromen-2-one (Example 29) following the procedure outlined in Example 25. 1H NMR (400 MHz, DMSO-d6): δ 9.51 (s, 1H), 8.81 (s, 2H), 7.94 (d, 1H), 7.20 (d, 1H), 4.64 (s, 1H), 4.03 (q, 2H), 3.98 (t, 2H), 3.91 (s, 3H), 2.36 (t, 2H), 1.80-1.60 (m, 4H), 1.15 (t, 3H); MS (ESI): 480.9.
Quellen und Nachweise
- ORD-Eintrag
- ord-46ab00e3f29145538a5a68903f22d573
- Quelldatensatz
- uspto-grants-2010_06
- Patentnummer
- US07745646B2
Verknüpfte Notizen
Wird geladen…